Clinical Trial Update: To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated immunogenicity, reactogenicity, and safety of two formulations of GSK's Rotarix (live attenuated human rotavirus vaccine) given as a t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED | Results posted: 2017-02-23